SMALTIS is a company created by two young doctors in bacteriology, Sophie GUENARD and Cédric MULLER. Its team is composed of microbiology experts, who aim to support various public and private actors in their health product development projects, from research to clinical studies. SMALTIS thus, offers tailor-made solutions with high added value, to fight against antibiotic resistance, to explore microbiota, and to optimize bioprocesses through bacterial strain engineering. SMALTIS’ services and products allow, for example, to assess the risk of antimicrobial resistance of new antimicrobial candidates, to understand the interactions between a compound and the intestinal microbiota, or to build a modified bacterial strain to simplify a bioproduction process. Catalogues of clinical or reference strains, genetically modified or not, well characterized, are also available, as well as analytical services. In order to ensure a high level of quality for its customers, the laboratory is certified ISO 9001.